Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 19617 NEW YORK, NY
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,910,160
-$163,731 QoQ
Shares Held
363,316
-5.1% QoQ
Ownership
0.365%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 209 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 85% Shared 0% None 15%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,256,291 across 425 Biotechnology names. SPRY ranks #134 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in SPRY

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,910,160 363,316
2026-03-31 $3,073,891 382,801
2025-12-31 $4,859,098 417,090
2025-09-30 $352,341 35,059
2025-06-30 $603,071 34,560
2025-03-31 $405,112 32,203
2024-12-31 $328,230 31,112
2024-09-30 $475,919 32,822
2024-06-30 $280,829 33,000
2024-03-31 $512,869 50,183
2023-12-31 $189,875 34,649
2023-09-30 $129,578 34,280
2023-06-30 $150,977 22,534
2023-03-31 $19,022 2,922
2022-12-31 $21,939 2,572
2022-09-30 $11,146 2,111
2022-06-30 $6,347 1,497
2022-03-31 $48,290 13,758
2021-12-31 $1,144,347 171,824
2021-09-30 $495,504 49,650
2021-06-30 $280,943 9,095
2021-03-31 $1,236,910 28,350